関西医科大学附属病院 耳鼻咽喉科・頭頸部外科／准教授
日本耳鼻咽喉科頭頸部外科学会 耳鼻咽喉科専門医・耳鼻咽喉科専門研修指導医 日本耳鼻咽喉科臨床学会 会員 日本頭頸部癌学会 代議員（耳鼻咽喉科・頭頸部外科） 日本頭頸部外科学会 評議員・頭頸部がん専門医・指導医 日本口腔・咽頭科学会 編集委員会 委員・植込み型舌下神経電気刺激療法推進委員会 委員 日本内分泌外科学会 内分泌外科専門医 日本唾液腺学会 会員 日本気管食道科学会 気管食道科専門医 日本耳鼻咽喉科免疫アレルギー感染症学会 会員 日本がん治療認定医機構 がん治療認定医
2004年
関西医科大学 医学部
卒業
2004年
関西医科大学 卒後臨床研修センター
研修医
2006年
関西医科大学附属枚方病院（現・関西医科大学附属病院）耳鼻咽喉科・頭頸部外科
研究医員
2007年
関西医科大学附属枚方病院（現・関西医科大学附属病院）耳鼻咽喉科・頭頸部外科
専修医
2008年
関西医科大学附属滝井病院（現・関西医科大学総合医療センター）耳鼻咽喉科
助教
2009年
関西医科大学附属枚方病院（現・関西医科大学附属病院）耳鼻咽喉科・頭頸部外科
助教
2010年
国立がん研究センター東病院 頭頸部外科
がん専門修練医
2012年
関西医科大学附属枚方病院（現・関西医科大学附属病院）耳鼻咽喉科・頭頸部外科
助教
2018年
関西医科大学附属病院 耳鼻咽喉科・頭頸部外科
研究医員
2021年
関西医科大学附属病院 耳鼻咽喉科・頭頸部外科
助教
2022年
関西医科大学附属病院 耳鼻咽喉科・頭頸部外科
講師
2023年
米国Stanford University School of Medicine, Department of Otolaryngology - Head & Neck Surgery,
Visiting Associate Professor
2024年
関西医科大学附属病院 耳鼻咽喉科・頭頸部外科
准教授
1. Relationship between the effectiveness of pembrolizumab monotherapy and ABO blood type in recurrent and metastatic squamous cell carcinoma of the head and neck. Discov Oncol. 2025 Jul 10;16(1):1302. doi: 10.1007/s12672-025-03105-x.
Shogen Boku, Tatsuki Ikoma, Tomoyo Yasuda, Nobuhiro Shibata, Tomofumi Sakagami, Kensuke Suzuki, Takuo Fujisawa, Hiroshi Iwai, Masashi Kanai.
2. Re-evaluation of histopathological factors for the outcome of salivary duct carcinoma patients: A multi-institutional retrospective study of 240 cases in a Japanese cohort. Human Pathology Volume 155, January 2025, 105736.
Kimihide Kusafuka, Eiji Nakatani, Satoshi Baba, Yoshifumi Arai, Matsuyoshi Maeda, Koji Yamanegi, Takayuki Murase, Hiroshi Inagaki, Yoshiro Otsuki, Kensuke Suzuki, Hiroshi Iwai, Yoshiaki Imamura, Shoji Yamanaka, Ichiro Ito, Midori Sato, Morito Kurata, Tsutomu Daa, Tomonori Kawasaki, Ryo Kawata, Yuri Tachibana, Junya Fukuoka, Takashi Suzuki, Hidetaka Yamamoto, Kazumori Arai, Makoto Suzuki.
3. CCL4 Affects Eosinophil Survival via the Shedding of the MUC1 N-Terminal Domain in Airway Inflammation. Cells 2025, 14, 33.
Yoshiki Kobayashi, Chu Hong Hanh, Naoto Yagi, Nhi Kieu Thi Le, Yasutaka Yun, Akihiro Shimamura, Kenta Fukui, Akitoshi Mitani, Kensuke Suzuki, Akira Kanda and Hiroshi Iwai.
4. Application of the ORBEYE Three-Dimensional Exoscope for Parotidectomies. J. Clin. Med. 2025, 14, 47.
Masao Yagi, Tomofumi Sakagami, Minaki Shimizu, Yuhei Ogino, Mizuki Morita, Hiroto Kawasaki, Atsushi Tomoda, Yasutaka Yun, Kensuke Suzuki, Takuo Fujisawa and Hiroshi Iwai.
5. Effectiveness and outcomes of endoscopic resection for superficial pharyngeal squamous cell carcinomas. Head & Neck. 2024;1–9. DOI: 10.1002/hed.27924.
Nakamura Naohiro, Sakagami Tomofumi, Shimizu Minaki, Suzuki Kensuke, Fujisawa Takuo, Shijimaya Takuya, Kobayashi Sanshiro, Takahashi Yu, Tahara Tomomitsu, Noda Yuri, Tsuta Koji, Naganuma Makoto.
6. Efficacy of minor salivary glands as indicators of depth of resection for superficial hypopharyngeal carcinoma. OTO Open 2024, Vol. 8(3):e182.
Tomofumi Sakagami, Yuri Noda, Naohiro Nakamura, Kensuke Suzuki, Takuo Fujisawa, Masao Yagi, Hiroto Kawasaki, Hiromasa Egawa, Wataru Sumita, Koji Tuta, Hiroshi Iwai.
7. CD69 signaling on eosinophils induces IL-10 production and apoptosis via the Erk1/2 and JNK pathways, respectively. Biomolecules 2024, 14(3), 360.
Dan Van Bui, Linh Manh Nguyen, Akira Kanda, Hanh Hong Chu, Nhi, Kieu Thi Le, Yasutaka Yun, Yoshiki Kobayashi, Kensuke Suzuki, Akitoshi Mitani, Akihiro Shimamura, Kenta Fukui, Shunsuke Sawada, David Dombrowicz, Hiroshi Iwai.
8. Mouse eosinophil-associated ribonuclease-2 exacerbates the allergic response. Allergy. 2024;00:1–5. DOI: 10.1111/all.16061.
Linh Manh Nguyen, Akira Kanda, Yuji Kamioka, Keizo Tokuhiro, Yoshiki Kobayashi, Yun Yasutaka, Dan Van Bui, Hanh Hong Chu, Nhi Kieu Thi Le, Kensuke Suzuki, Akitoshi Mitani, Akihiro Shimamura, Kenta Fukui, David Dombrowicz, Hiroshi Iwai.
9. The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition. Cells 2023, 12, 2746.
Yoshiki Kobayashi, Hanh Hong Chu, Dan Van Bui, Yasutaka Yun, Linh Manh Nguyen, Akitoshi Mitani, Kensuke Suzuki, Mikiya Asako, Akira Kanda and Hiroshi Iwai.
10. Direct specimen collection during routine operation improves nucleic acid quality in genetic analysis samples for head and neck tumors: a retrospective study. Pathology - Research and Practice 252: 154943, 2023.
Yuri Noda, Tomofumi Sakagami, Kensuke Suzuki, Takuo Fujisawa, Masao Yagi, Hiroshi Iwai, Koji Tsuta.
11. Successful endoscopic resection for well-differentiated neuroendocrine tumor, Grade 1, in the hypopharynx. Clin J Gastroenterol (2023).
Naohiro Nakamura, Tomofumi Sakagami, Kensuke Suzuki, Yu Takahashi, Yuri Noda, Koji Tsuta, Makoto Naganuma.
12. Head and Neck Solitary Fibrous Tumor Presenting as Salivary Gland Tumor: Two Case Reports and Review of the Literature. Case Reports in Oncology 16:456–464, 2023.
Kensuke Suzuki, Yuri Noda, Tomofumi Sakagami, Masao Yagi, Kimihide Kusafuka, Hiroshi Iwai.
13. Inoculation of Lymphocytes from Young Mice Prevents Progression of Age-Related Hearing Loss in a Senescence-Associated Mouse Model. Experimental Gerontology 177; 112184, 2023 Apr 25; Doi: 10.1016/j.exger.2023.112184.
Akitoshi Mitani, Hiroshi Iwai, Muneo Inaba, Dan Van Bui, Toru Miwa, Linh Manh Nguyen, Chu Hong Hanh, Tomofumi Sakagami, Kensuke Suzuki, Yoshiki Kobayashi, Yasutaka Yun, Yuuki Sugita, Akira Kanda.
14. CCL4 regulates eosinophil activation in eosinophilic airway inflammation. Int. J. Mol. Sci. 2022, 23(24), 16149.
Hanh Hong Chu, Yoshiki Kobayashi, Dan Van Bui, Yasutaka Yun, Linh Manh Nguyen, Akitoshi Mitani, Kensuke Suzuki, Mikiya Asako, Akira Kanda, Hiroshi Iwai.
15. Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model. Int J Mol Sci 2022, 23(17), 9872.
Kensuke Suzuki, Hiroshi Iwai, Keita Utsunomiya, Yumiko Kono, Tadashi Watabe, Yoshiki Kobayashi, Dan Van Bui, Shunsuke Sawada, Yasutaka Yun, Akitoshi Mitani, Kenta Fukui, Haruka Sakai, Hanh Hong Chu, Nguyen Manh Linh, Noboru Tanigawa and Akira Kanda.
16. CCL4 functions as a biomarker of type 2 airway inflammation. Biomedicines 2022, 10(8), 1779.
Yoshiki Kobayashi, Hanh Hong Chu, Akira Kanda, Yasutaka Yun, Masami Shimono, Linh Manh Nguyen, Akitoshi Mitani, Kensuke Suzuki, Mikiya Asako, Hiroshi Iwai.
17. Efficacy of Nanofiber Sheets Incorporating Lenvatinib in a Hepatocellular Carcinoma Xenograft Model. Nanomaterials 2022, 12(8), 1364.
Terufumi Yoshida, Masaki Kaibori, Nanami Fujisawa, Mariko Ishizuka, Fusao Sumiyama, Masahiko Hatta, Hisashi Kosaka, Kosuke Matsui, Kensuke Suzuki, Tomoya O Akama, Tayo Katano, Kengo Yoshii, Mitsuhiro Ebara and Mitsugu Sekimoto.
18. The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan. Head & Neck. 2022, 44(6); 1430–1441. DOI: 10.1002/hed.27034.
Kimihide Kusafuka, Yoko Sato, Eiji Nakatani, Satoshi Baba, Matsuyoshi Maeda, Koji Yamanegi, Kaori Ueda, Hiroshi Inagaki, Yoshiro Otsuki, Naoto Kuroda, Kensuke Suzuki, Hiroshi Iwai, Yoshiaki Imamura, Junya Itakura, Shoji Yamanaka, Hideaki Takahashi, Ichiro Ito, Takumi Akashi, Tsutomu Daa, Mei Hamada, Masanori Yasuda, Ryo Kawata, Hidetaka Yamamoto, Yuri Tachibana, Junya Fukuoka, Aya Muramatsu, Kazumori Arai, Makoto Suzuki.
19. Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report. BMC Medical Genomics 15:6, 2022.
Kensuke Suzuki, Hiroshi Harada, Masayuki Takeda, Chisato Ohe, Yoshiko Uemura, Akihiko Kawahara, Shunsuke Sawada, Akira Kanda, Bhaswati Sengupta and Hiroshi Iwai.
20. Treg and IL-1 Receptor Type 2-Expressing CD4+ T Cell-Deleted CD4+ T Cell Fraction Prevents the Progression of Age-Related Hearing Loss in a Mouse Model. Journal of Neuroimmunology 357: 577628, 2021.
Hiroshi Iwai, Muneo Inaba, Dan Van Bui, Kensuke Suzuki, Tomofumi Sakagami, Yasutaka Yun, Akitoshi Mitani, Yoshiki Kobayashi, Akira Kanda.
21. Combination therapy with lenvatinib and radiation significantly inhibits thyroid cancer growth by uptake of tyrosine kinase inhibitor. Experimental Cell Research 398: 112390, 2021.
Kensuke Suzuki, Hiroshi Iwai, Keita Utsunomiya, Yumiko Kono, Yoshiki Kobayashi, Dan Van Bui, Shunsuke Sawada, Yasutaka Yun, Akitoshi Mitani, Naoyuki Kondo, Tayo Katano, Noboru Tanigawa, Tomoya Akama, Akira Kanda.
22. The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions. Allergology International ,2020.
Akira Kanda, Yasutaka Yun, Dan Van Bui, Linh Manh Nguyen,Yoshiki Kobayashi, Kensuke Suzuki, Akitoshi Mitani, Shunsuke Sawada,Satoko Hamada, Mikiya Asako, Hiroshi Iwai.
23. Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings. Allergology International 69(2):232-238, 2020.
Yasutaka Yun, Akira Kanda, Yoshiki Kobayashi, Dan Van Bui, Kensuke Suzuki, Shunsuke Sawada, Kazuyasu Baba, Masao Yagi, Mikiya Asako, Haruka Okazaki, Hiroki Ikeda, Shigeki Kawamura, Akihiko Nakamura, David Dombrowicz, Koichi Tomoda, Hiroshi Iwai.
24. Radioiodine (I-131) Ablation in Outpatient After Total Thyroidectomy for the Differentiated Thyroid Cancer. Bio Med J of Sci ＆ Tech Res 24(1):17872-17879, 2019. DOI: 10.26717/BJSTR.2019.24.003980.
Naoki Kan, Keita Utsunomiya, Yumiko Kono, Kensuke Suzuki, Hiroshi Iwai, Yasuhiro Ueno, Kaoru Maruyama and Noboru Tanigawa.
25. Quantitative immunohistochemical assay with novel digital immunostaining for comparison of PD-L1 antibodies. Molecular and Clinical Oncology 10: 391-396, 2019. DOI: 10.3892/mco.2019.1801.
Takuo Fujisawa, Koji Tsuta, Hiroaki Yanagimoto, Masao Yagi, Kensuke Suzuki, Kenji Nishikawa, Masaru Takahashi, Hisatake Okada, Yasushi Nakano, Hiroshi Iwai.
26. A comparison of short-term outcomes of neck dissection for head and neck cancers using Thunderbeat™, LigaSure™ or treatment without an energybased device: A case controlled study. Int J Surg 58 (2018) 60-64.
Kensuke Suzuki, Minaki Shimizu, Tomofumi Sakagami, Masao Yagi, Takuo Fujisawa, Shunsuke Sawada, Akira Kanda, Yoshiki Kobayashi, Hiroshi Iwai.
27. Indications for partial parotidectomy using retrograde dissection of the marginal mandibular branch of the facial nerve for benign tumours of the parotid gland. Br J Oral Maxillofac Surg 56(8):727-731 (2018) DOI: https://doi.org/10.1016/j.bjoms.2018.08.002.
Kensuke Suzuki, Hiroshi Iwai, Masao Yagi, Takuo Fujisawa, Akira Kanda, Masaya Konishi, Yoshiki Kobayashi, Koichi Tomoda, Toshio Yamashita.
28. Mammary Analogue Secretory Carcinoma Presenting as a Cervical Lymph Node Metastasis of Unknown Primary Site: A Case Report. Case Reports in Oncology 10: 192-198, 2017.
Kensuke Suzuki, Masao Yagi, Akira Kanda, Yoshiki Kobayashi, Masaya Konishi, Chika Miyasaka, Takashi Tashiro, Hiroshi Iwai.
29. The Effectiveness of Chemoradiation Therapy and Salvage Surgery for Hypopharyngeal Squamous Cell Carcinoma. JJCO 43: 1210-1217, 2013.
Kensuke Suzuki, Ryuichi Hayashi, Mitsuru Ebihara, Masakazu Miyazaki, Takeshi Shinozaki, Hiroyuki Daiko, Minoru Sakuraba, Sadamoto Zenda, Makoto Tahara, Satoshi Fujii.
30. Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx. Int J Clin Oncol 18: 454-63, 2013.
Satoshi Fujii, Hideoki Uryu, Ken Akashi, Kensuke Suzuki, Manabu Yamazaki, Makoto Tahara, Ryuichi Hayashi, Atsushi Ochiai.
1. 鈴木健介，岩井大：ガマ腫［私の治療］．日本医事新報No.5162：47，2023．
2. 鈴木健介：唾液腺腫脹［今日の治療指針 私はこう治療している vol.65］．福井次矢，高木誠，小室一成 編，医学書院，東京：1596-1597，2023．
3. 鈴木健介，岩井大：中咽頭癌［私の治療］．日本医事新報No.4992：55，2019．
1. 2024年 加多乃会研究助成（第42回研究助成「加多乃賞」）「レンバチニブ含有ポリカプロラクトンシートと放射線外照射の併用による新たな難治性甲状腺癌治療法の開発」
2. 2021年 第21回関西医科大学医学会賞（第一位）「Combination Therapy with Lenvatinib and Radiation Significantly Inhibits Thyroid Cancer Growth by Uptake of Tyrosine Kinase Inhibitor」
3. 2015年 第32回Pan-Pacific Surgical Association Japan Chapter Wada Award（ポスター賞）「Retrospective review of 267 cases of parotidectomy for benign parotid grand tumors」
【競争的研究費】1. 2025年 科学研究費助成事業 若手研究採択：課題名「ナトリウムヨウ素共輸送体の機能亢進と腫瘍血管正常化によるI-131抵抗性の克服」
【競争的研究費】2. 2022年 科学研究費助成事業 若手研究採択：課題名「I-131抵抗性の克服による甲状腺癌に対する新規分子標的薬併用放射線療法の開発」
【競争的研究費】3. 2017年 日本私立学校振興・共済事業団学術研究振興資金（若手研究者奨励金）：課題名「ヒト唾液腺悪性腫瘍におけるがん幹細胞の検討」
【新聞】 読売新聞 病院の実力「甲状腺がん」掲載（2025年4月27日発行）
本ページにおける情報は、医師本人の申告に基づいて掲載しております。内容については弊社においても可能な限り配慮しておりますが、最新の情報については公開情報等をご確認いただき、またご自身でお問い合わせいただきますようお願いします。
なお、弊社はいかなる場合にも、掲載された情報の誤り、不正確等にもとづく損害に対して責任を負わないものとします。